410 related articles for article (PubMed ID: 11244022)
1. Restoration of nitric oxide availability after calcium antagonist treatment in essential hypertension.
Taddei S; Virdis A; Ghiadoni L; Magagna A; Favilla S; Pompella A; Salvetti A
Hypertension; 2001 Mar; 37(3):943-8. PubMed ID: 11244022
[TBL] [Abstract][Full Text] [Related]
2. Calcium antagonist treatment by lercanidipine prevents hyperpolarization in essential hypertension.
Taddei S; Virdis A; Ghiadoni L; Versari D; Salvetti G; Magagna A; Salvetti A
Hypertension; 2003 Apr; 41(4):950-5. PubMed ID: 12642509
[TBL] [Abstract][Full Text] [Related]
3. Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension.
Taddei S; Virdis A; Ghiadoni L; Magagna A; Salvetti A
Circulation; 1998 Jun; 97(22):2222-9. PubMed ID: 9631871
[TBL] [Abstract][Full Text] [Related]
4. Effect of calcium antagonist or beta blockade treatment on nitric oxide-dependent vasodilation and oxidative stress in essential hypertensive patients.
Taddei S; Virdis A; Ghiadoni L; Magagna A; Pasini AF; Garbin U; Cominacini L; Salvetti A
J Hypertens; 2001 Aug; 19(8):1379-86. PubMed ID: 11518845
[TBL] [Abstract][Full Text] [Related]
5. Age-related reduction of NO availability and oxidative stress in humans.
Taddei S; Virdis A; Ghiadoni L; Salvetti G; Bernini G; Magagna A; Salvetti A
Hypertension; 2001 Aug; 38(2):274-9. PubMed ID: 11509489
[TBL] [Abstract][Full Text] [Related]
6. Physical activity prevents age-related impairment in nitric oxide availability in elderly athletes.
Taddei S; Galetta F; Virdis A; Ghiadoni L; Salvetti G; Franzoni F; Giusti C; Salvetti A
Circulation; 2000 Jun; 101(25):2896-901. PubMed ID: 10869260
[TBL] [Abstract][Full Text] [Related]
7. Vasodilation to bradykinin is mediated by an ouabain-sensitive pathway as a compensatory mechanism for impaired nitric oxide availability in essential hypertensive patients.
Taddei S; Ghiadoni L; Virdis A; Buralli S; Salvetti A
Circulation; 1999 Sep; 100(13):1400-5. PubMed ID: 10500040
[TBL] [Abstract][Full Text] [Related]
8. Identification of a cytochrome P450 2C9-derived endothelium-derived hyperpolarizing factor in essential hypertensive patients.
Taddei S; Versari D; Cipriano A; Ghiadoni L; Galetta F; Franzoni F; Magagna A; Virdis A; Salvetti A
J Am Coll Cardiol; 2006 Aug; 48(3):508-15. PubMed ID: 16875977
[TBL] [Abstract][Full Text] [Related]
9. Tetrahydrobiopterin improves endothelium-dependent vasodilation in chronic smokers : evidence for a dysfunctional nitric oxide synthase.
Heitzer T; Brockhoff C; Mayer B; Warnholtz A; Mollnau H; Henne S; Meinertz T; Münzel T
Circ Res; 2000 Feb; 86(2):E36-41. PubMed ID: 10666424
[TBL] [Abstract][Full Text] [Related]
10. Effect of oral contraceptives on endothelial function in the peripheral microcirculation of healthy women.
Virdis A; Pinto S; Versari D; Salvetti G; Bernini G; Fruzzetti F; Genazzani AR; Taddei S; Salvetti A
J Hypertens; 2003 Dec; 21(12):2275-80. PubMed ID: 14654747
[TBL] [Abstract][Full Text] [Related]
11. Effect of insulin on acetylcholine-induced vasodilation in normotensive subjects and patients with essential hypertension.
Taddei S; Virdis A; Mattei P; Natali A; Ferrannini E; Salvetti A
Circulation; 1995 Nov; 92(10):2911-8. PubMed ID: 7586259
[TBL] [Abstract][Full Text] [Related]
12. Cyclooxygenase inhibition restores nitric oxide activity in essential hypertension.
Taddei S; Virdis A; Ghiadoni L; Magagna A; Salvetti A
Hypertension; 1997 Jan; 29(1 Pt 2):274-9. PubMed ID: 9039114
[TBL] [Abstract][Full Text] [Related]
13. Does lipoprotein(a) impair endothelial function?
Schlaich MP; John S; Langenfeld MR; Lackner KJ; Schmitz G; Schmieder RE
J Am Coll Cardiol; 1998 Feb; 31(2):359-65. PubMed ID: 9462580
[TBL] [Abstract][Full Text] [Related]
14. Nitric oxide modulates tissue plasminogen activator release in normotensive subjects and hypertensive patients.
Giannarelli C; De Negri F; Virdis A; Ghiadoni L; Cipriano A; Magagna A; Taddei S; Salvetti A
Hypertension; 2007 Apr; 49(4):878-84. PubMed ID: 17339540
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms responsible for endothelial dysfunction induced by fasting hyperhomocystinemia in normotensive subjects and patients with essential hypertension.
Virdis A; Ghiadoni L; Cardinal H; Favilla S; Duranti P; Birindelli R; Magagna A; Bernini G; Salvetti G; Taddei S; Salvetti A
J Am Coll Cardiol; 2001 Oct; 38(4):1106-15. PubMed ID: 11583890
[TBL] [Abstract][Full Text] [Related]
16. beta-Adrenoceptor-mediated, nitric-oxide-dependent vasodilatation is abnormal in early hypertension: restoration by L-arginine.
Schlaich MP; Ahlers BA; Parnell MM; Kaye DM
J Hypertens; 2004 Oct; 22(10):1917-25. PubMed ID: 15361763
[TBL] [Abstract][Full Text] [Related]
17. Impaired endothelium-dependent vasodilatation in subclinical hypothyroidism: beneficial effect of levothyroxine therapy.
Taddei S; Caraccio N; Virdis A; Dardano A; Versari D; Ghiadoni L; Salvetti A; Ferrannini E; Monzani F
J Clin Endocrinol Metab; 2003 Aug; 88(8):3731-7. PubMed ID: 12915662
[TBL] [Abstract][Full Text] [Related]
18. Effects of angiotensin converting enzyme inhibitor and calcium antagonist on endothelial function in patients with essential hypertension.
On YK; Kim CH; Oh BH; Lee MM; Park YB
Hypertens Res; 2002 May; 25(3):365-71. PubMed ID: 12135314
[TBL] [Abstract][Full Text] [Related]
19. Ghrelin restores nitric oxide availability in resistance circulation of essential hypertensive patients: role of NAD(P)H oxidase.
Virdis A; Duranti E; Colucci R; Ippolito C; Tirotta E; Lorenzini G; Bernardini N; Blandizzi C; Taddei S
Eur Heart J; 2015 Nov; 36(43):3023-30. PubMed ID: 26224075
[TBL] [Abstract][Full Text] [Related]
20. Low-grade systemic inflammation causes endothelial dysfunction in patients with Hashimoto's thyroiditis.
Taddei S; Caraccio N; Virdis A; Dardano A; Versari D; Ghiadoni L; Ferrannini E; Salvetti A; Monzani F
J Clin Endocrinol Metab; 2006 Dec; 91(12):5076-82. PubMed ID: 16968790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
